ArticleJournal of Ayurveda and integrative medicine
How do we dynamically evolve AYUSH COVID-19 guidelines in real-time to further empower people and
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- A systematic review on impact of SARS-CoV-2 infection.Microbiological research · 2023Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The crisis of the second wave of COVID-19 in India is anticipated to peak over the next few weeks, stressing the healthcare system further. India has the unique strength of AYUSH with access to safe traditional medications, certain scientifically validated interventions, a highly skilled resource pool of nationwide vaidyas who are willing to engage with its leadership. The excellent foundations laid for COVID-19 response by AYUSH can be further developed to empower people and the vaidyas. The current guidelines are based on classical references, biological plausibility and scientific studies done in a conventional mode. It is now an opportune time to document clinical observations, identify symptom specific interventions and engage with mainstream management to evolve Integrative Ayurveda guidelines for COVID-19 management. This article discusses the premise and the details of the next steps. There is a hope that a conducive environment created by AYUSH will alter the landscape of Integrative Medicine and health in India, inspiring global health practices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.